179 results on '"Wilson Tang, W.H."'
Search Results
2. NT-proBNP and cardiovascular event risk in individuals with prediabetes undergoing cardiovascular evaluation
3. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study
4. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
5. Future Therapies in HFpEF
6. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data
7. Primary Results From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy
8. Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms
9. Usefulness of Neutrophil-to-Lymphocyte Ratio in Risk Stratification of Patients With Advanced Heart Failure
10. Incidence, Predictors, and Impact on Survival of Left Ventricular Systolic Dysfunction and Recovery in Advanced Cancer Patients
11. Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research
12. Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee
13. Impact of Left Ventricular Remodeling on Diagnostic and Prognostic Value of Tissue Doppler Indices in Chronic Systolic Heart Failure
14. List of Contributors
15. Cardiovascular Biomarker Assessment Across Glycemic Status
16. Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic Therapy
17. 36 - Future Therapies in HFpEF
18. Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
19. B-AB15-01 PROGNOSTIC IMPLICATIONS OF PURE MONOMORPHIC VENTRICULAR TACHYCARDIA IN ELECTRICAL STORM
20. B-AB15-02 SHORT AND LONG-TERM SURVIVAL OUTCOMES IN PATIENTS WITH ELECTRICAL STORM-INDUCED CARDIOGENIC SHOCK
21. Early and late effects of cardiac resynchronization therapy on force–frequency relation and contractility regulating gene expression in heart failure patients
22. Gender Differences in Patients Admitted With Advanced Decompensated Heart Failure
23. Evolving concepts in left ventricular systolic and diastolic remodeling: Implications for therapy
24. Natriuretic Peptides in Screening for Cardiac Dysfunction
25. Clinical Trials of Carvedilol in Heart Failure
26. Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort
27. Cardiorenal syndrome in decompensated heart failure
28. Comparative sensitivities betweendifferent plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure
29. Neurohormonal Upregulation in Heart Failure
30. Association of chromosome 9p21 with subsequent coronary heart disease events : a GENIUS-CHD study of individual participant data
31. Coronary revascularization for treatment of heart failure: optimal patient selection
32. Ischemic heart disease and congestive heart failure in diabetic patients
33. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
34. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
35. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure
36. POLYPHARMACY OF HEART FAILURE: Creating a Rational Pharmacotherapeutic Protocol
37. Chapter 21 - Cardiovascular Biomarker Assessment Across Glycemic Status
38. Navigating air travel and cardiovascular concerns: Is the sky the limit?
39. Echocardiographic Predictors of Long‐Term Survival in Patients Undergoing Cardiac Resynchronization Therapy: What Is the Optimal Metric?
40. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure
41. Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study)
42. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF
43. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes
44. The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF
45. Prognostic Implications of Serum Chloride Levels in Patients with Stable Heart Failure
46. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
47. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
48. Prognostic Value of Glomerular Filtration Estimates versus Natriuretic Response in Decompensated Heart Failure Patients with Reduced Ejection Fraction Who Achieve Effective Decongestion
49. Improving Anti-Oxidative Lactonase and Arylesterase Activities Predict Improved Long-Term Clinical Outcomes in Acute Decompensated Heart Failure
50. Vascular Markers, Emerging Biomarkers in Heart Failure with Preserved Ejection Fraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.